Astrocytes, Not Neurons, Mediate Norepinephrine’s Effects on Synapses
Summary: For decades, neuroscientists assumed neuromodulators such as norepinephrine influenced brain circuits by acting directly on neurons. New research from Washington University School of Medicine overturns that view: astrocytes—glial support cells often overlooked—act as the primary intermediaries. When norepinephrine is released, astrocytes detect it and release their own signaling molecules, which suppress synaptic activity and reorganize neuronal connections. These effects persist even if neurons cannot directly sense norepinephrine, provided astrocytes remain responsive.
Key Facts:
- Astrocyte mediation: Norepinephrine reshapes brain connectivity primarily by signaling through astrocytes rather than acting directly on neurons.
- Synaptic dampening: Activated astrocytes release a secondary messenger that reduces synaptic strength and alters presynaptic efficacy.
- Therapeutic potential: Targeting astrocytes could open new avenues for treating attention, memory and mood disorders that involve norepinephrine signaling.
Source: WUSTL
Researchers at Washington University School of Medicine in St. Louis report a major shift in how we understand the modulation of brain networks during states of heightened attention and vigilance. Their findings, published in Science on May 15, show that norepinephrine—a neuromodulator linked to alertness, attention and learning—acts through astrocytes to change synaptic function and circuit connectivity.
Traditionally, textbooks and much of neuroscience have emphasized neurons as the primary targets of neuromodulatory signaling. The new results challenge that neuron-centric view and propose that astrocytes, with their extensive processes and intimate contacts with synapses, are ideally suited to detect neuromodulators and reshape communication across neural circuits on slower timescales.
Astrocytes as active regulators of synapses
Astrocytes have long been known to physically associate with synapses, but the functional consequences of that relationship have been debated. Papouin and colleagues tested whether norepinephrine-mediated remodeling of synapses depends on astrocytes. Using mouse brain slices and experiments that stimulated norepinephrine release, the team confirmed that norepinephrine reduces synaptic strength, as previously reported. Crucially, they discovered that this suppression occurs only after astrocytes are activated by norepinephrine and release a secondary chemical messenger onto synapses.
The researchers demonstrated that blocking neurons’ direct sensing of norepinephrine did not prevent norepinephrine from reorganizing synaptic connectivity. In contrast, disrupting astrocytes’ ability to detect or respond to norepinephrine abolished the neuromodulator’s effects on synapses. These results indicate that astrocytic adrenergic receptors and calcium dynamics gate norepinephrine’s impact on synaptic function.
Mechanistically, the team found that norepinephrine’s suppression of synaptic strength is mediated by an ATP-derived signal that acts through A1 adenosine receptors to reduce presynaptic efficacy. This signaling cascade positions astrocytes as a central circuit effector: they translate neuromodulatory cues into changes in synaptic transmission and network connectivity.
Implications for treatment and research
Beyond revising fundamental ideas about neuromodulation and circuit control, these findings carry potential clinical implications. Many psychiatric and neurological treatments influence norepinephrine signaling—for example, in ADHD and depression. If those drugs depend on astrocyte-mediated mechanisms to reshape brain activity, directly targeting astrocytes might offer new therapeutic strategies or increase drug efficacy.
Papouin’s group has begun examining existing medications thought to act on neuronal receptors to determine whether their effects also require astrocytes. If astrocytes are essential mediators for many such drugs, they could become deliberate targets for interventions designed to restore healthy patterns of attention, mood and memory.
Funding: This research was supported by National Institutes of Health grants R01MH127163-01, R01DK128475, R01NS102272 and R01HL31113-30; Department of Defense grant W911NF-21-1-0312; The Brain & Behavior Research Foundation NARSAD Young Investigator Award 28616; The Whitehall Foundation grant 2020-08-35; and The McDonnell Center for Cellular and Molecular Neurobiology Award 22-3930-26275U. The content is the authors’ responsibility and does not necessarily represent NIH views.
About this neuroscience research news
Author: Mark Reynolds
Source: WUSTL
Contact: Mark Reynolds – WUSTL
Image: The image is credited to Neuroscience News
Original Research: Closed access. “Norepinephrine signals through astrocytes to modulate synapses” by Thomas Papouin et al. Science.
Abstract
Norepinephrine signals through astrocytes to modulate synapses
Locus ceruleus–derived norepinephrine drives network and behavioral adaptations to salient environmental cues by reconfiguring circuit functional connectivity, but the synapse-level mechanisms were previously unclear. This study shows that norepinephrine’s remodeling of synaptic function does not require binding to neuronal receptors. Instead, astrocytic adrenergic receptors and intracellular calcium dynamics fully gate norepinephrine’s effect on synapses. Norepinephrine’s suppression of synaptic strength stems from an ATP-derived signal that, via A1 adenosine receptors, controls presynaptic efficacy. These findings identify astrocytes as core components of neuromodulatory systems and the circuit effectors through which norepinephrine produces network and behavioral adaptations.